Firm Announcement

On 15 November 2023, The Legal 500, a leading international legal directory, released its 2024 Asia Pacific rankings. King & Wood Mallesons (KWM) was recognized in 44 practice areas, with 28 Tier 1 practice area rankings. Of the 211 individuals on the list, 12 were named to the Hall of the Fame, 39 were ranked as Leading Individuals, 29 as Next Generation Partners, 15 as Rising Stars, and 138 were highly recommended lawyers in their respective practice areas.

17 November 2023

Firm Announcement

On 12 November 2023, King & Wood Mallesons (KWM) received three prestigious awards in recognition of the outstanding contributions to legal services related to the Belt and Road Initiative (BRI). The accolades were presented during the Fifth Belt and Road Initiative (BRI) Legal Service Typical Cases Conference, hosted by Legal Daily and organised by legaldaily.com in Beijing. The event brought together more than 200 guests from the Supreme People’s Court, the Ministry of Justice, the State-owned Assets Supervision and Administration Commission of the State Council, the China Law Society, the Belt and Road International Lawyers Association (BRILA), arbitration institutions, law schools, law firms and enterprises. Wu Wei and Wang Yue, partners of KWM, were present in the event and received the awards on behalf of the firm.

13 November 2023

Firm Announcement

The first edition of the Pharmaceuticals and the Law - A Guide to the Chinese Pharmaceuticals and Healthcare Market (Pharmaceuticals and the Law) was widely welcomed by readers since its launch in 2015. In recent years, the pharmaceuticals and healthcare industry in China has experienced significant transformations, driven by the full implementation of the Healthy China initiative and deep reforms to the pharmaceuticals and healthcare system. The foundational laws governing the industry have been revised, while new laws and regulations reflecting the changing times have been issued; various frameworks aligning with international standards have been put into practice; emerging businesses such as “online healthcare” are experiencing rapid growth. Additionally, China’s extensive anti-corruption campaign targeting the pharmaceutical and healthcare industry continues to intensify. Against this backdrop, the launch of the second edition of the Pharmaceuticals and the Law takes on greater significance.

26 October 2023